Berrend Gustian Muller MD, Presenter: Nothing to Disclose

Sandeep Sankineni MD, Abstract Co-Author: Nothing to Disclose

Osama Elbuluk, Abstract Co-Author: Nothing to Disclose

Kinzya Bernice Grant MD, Abstract Co-Author: Nothing to Disclose

Soroush Rais-Bahrami MD, Abstract Co-Author: Nothing to Disclose

Annerleim Walton-Diaz, Abstract Co-Author: Nothing to Disclose

Harsh Agarwal, Abstract Co-Author: Employee, Koninklijke Philips NV

Marcelino Bernardo BS, Abstract Co-Author: Nothing to Disclose

Bradford J. Wood MD, Abstract Co-Author: Researcher, Koninklijke Philips NV Researcher, Celsion Corporation Researcher, BTG International Ltd Researcher, , W. L. Gore & Associates, Inc Researcher, Delcath Systems, Inc Pending research funded, Perfint Healthcare Pvt Ltd Patent agreement, VitalDyne, Inc Intellectual property, Koninklijke Philips NV Intellectual property, BTG International Ltd

Peter Pinto, Abstract Co-Author: Nothing to Disclose

Peter L. Choyke MD, Abstract Co-Author: Researcher, Koninklijke Philips NV Researcher, General Electric Company Researcher, Siemens AG Researcher, iCAD, Inc Researcher, Aspyrian Therapeutics, Inc Researcher, ImaginAb, Inc Researcher, Aura

Baris Turkbey MD, Abstract Co-Author: Nothing to Disclose

Multi-parametric MRI (MP-MRI) has an important role in the management of prostate cancer. The technology has several clinical indications such as lesion detection, biopsy guidance and focal therapy. During the last decade, MP-MRI has been increasingly used in post-treatment follow up of prostate cancer and sometimes in treatment of benign prostatic hyperplasia. Given the large spectrum of treatment approaches (e.g. prostatectomy, focal laser ablation, radiotherapy, hormonal therapy, proton-beam therapy etc.), it is challenging for the interpreting radiologist to accurately evaluate the MP-MRI in the setting of treatment-related changes. The purpose of this exhibit is to present prostate MP-MRI findings of post-treatment patients and to provide tips to aid in the accurate evaluation of such cases.

Case presentations will cover representative examples of prostate MP-MRI from patients who underwent various treatments for cancer and BPH, along with a discussion of the key MRI features. The list of cases includes: 1. Simple prostatectomy 2. Radical prostatectomy 3. Radiotherapy (external beam and brachytherapy) 4. Hormone therapy 5. Focal laser ablation 6. Cryoablation 7. Proton beam therapy 8. HIFU 9. Vaccine-Immunotherapy  

http://abstract.rsna.org/uploads/2014/14019036/14019036_vcdv.pdf

Muller, B, Sankineni, S, Elbuluk, O, Grant, K, Rais-Bahrami, S, Walton-Diaz, A, Agarwal, H, Bernardo, M, Wood, B, Pinto, P, Choyke, P, Turkbey, B, Multi-Parametric MRI Findings of Post-Treatment Changes in the Prostate Gland.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14019036.html